Positron emission tomography scanning in the evaluation of hepatocellular carcinoma. - Wikidata - wikimedia - TriplyDB

Positron emission tomography scanning in the evaluation of hepatocellular carcinoma.

Positron emission tomography scanning in the evaluation of hepatocellular carcinoma.

http://www.wikidata.org/entity/Q33939061

about

Imaging of liver cancer.Prediction of hepatocellular carcinoma biological behavior in patient selection for liver transplantation Advances in computed tomography and magnetic resonance imaging of hepatocellular carcinoma Application of Different Imaging Methods in the Early Diagnosis of Primary Hepatic Carcinoma Predictive biomarkers of sorafenib efficacy in advanced hepatocellular carcinoma: Are we getting there?New approaches for precise response evaluation in hepatocellular carcinoma Yttrium-90 radioembolization of liver tumors: what do the images tell us?Multidisciplinary perspective of hepatocellular carcinoma: A Pacific Northwest experience.[18F]fludeoxyglucose positron emission tomography and computed tomography as a prognostic tool before liver transplantation, resection, and loco-ablative therapies for hepatocellular carcinoma.Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma.Usefulness of F-18 FDG PET/CT in the Evaluation of Early Treatment Response After Interventional Therapy for Hepatocellular Carcinoma.Evaluation of Bone Metastasis from Hepatocellular Carcinoma Using (18)F-FDG PET/CT and (99m)Tc-HDP Bone Scintigraphy: Characteristics of Soft Tissue Formation.Evaluation of 99mTc-3PRGD2 integrin receptor imaging in hepatocellular carcinoma tumour-bearing mice: comparison with 18F-FDG metabolic imaging.Inhibition of glucose turnover by 3-bromopyruvate counteracts pancreatic cancer stem cell features and sensitizes cells to gemcitabine.Differentiation between Malignant and Benign Solitary Lesions in the Liver with (18)FDG PET/CT: Accuracy of Age-related Diagnostic Standard.Early finding of chest wall metastasis of hepatocellular carcinoma in a woman by fluorodeoxyglucose-positron emission tomography scan: a case report 18F-Fluoro-2-deoxyglucose positron emission tomography in the evaluation of gastrointestinal malignancies.The potential use of 2-[¹⁸F]fluoro-2-deoxy-D-galactose as a PET/CT tracer for detection of hepatocellular carcinoma.Imaging of hepatocellular carcinoma patient-derived xenografts using ⁸⁹Zr-labeled anti-glypican-3 monoclonal antibody.Imaging for assessment of treatment response in hepatocellular carcinoma: Current update.Use of (18)F-FDG PET to predict tumor progression and survival in patients with intermediate hepatocellular carcinoma treated by transarterial chemoembolization.Causes and imaging features of false positives and false negatives on F-PET/CT in oncologic imaging Chronic Liver Disease and the Detection of Hepatocellular Carcinoma by [(18)F]fluorocholine PET/CT.Surgical management of hepatic malignancy.Functional imaging of hepatocellular carcinoma using diffusion-weighted MRI and (18)F-FDG PET/CT in patients on waiting-list for liver transplantation.Diagnostic value for extrahepatic metastases of hepatocellular carcinoma in positron emission tomography/computed tomography scan.Update of PET and PET/CT for hepatobiliary and pancreatic malignancies.Prognostic value of pretreatment (18)F-FDG PET-CT in radiotherapy for patients with hepatocellular carcinoma.Hepatocellular carcinoma: natural history, current management, and emerging tools.Positron emission tomography: clinical applications in oncology. Part 2.Metabolic characteristics distinguishing intrahepatic cholangiocarcinoma: a negative pilot study of (18)F-fluorocholine PET/CT clarified by transcriptomic analysis.PET-avid hepatocellular adenomas: incidental findings associated with HNF1-α mutated lesions Characterization of hepatic tumors using [11C]metomidate through positron emission tomography: comparison with [11C]acetate Molecular imaging of hepatocellular carcinoma xenografts with epidermal growth factor receptor targeted affibody probes [18F]Fluorodeoxyglucose accumulation as a biological marker of hypoxic status but not glucose transport ability in gastric cancer.Advantages of L-3-[(18)F] fluoro-alpha-methyl tyrosine over 2-[(18)F]-fluoro-2-deoxyglucose in detecting liver metastasis during positron emission tomography scan.Hepatic adenoma mimicking a metastatic lesion on computed tomography-positron emission tomography scan.Optimal 2-[(18)F]fluoro-2-deoxy-D-galactose PET/CT protocol for detection of hepatocellular carcinoma Predictive biomarkers of antiangiogenic therapy for advanced hepatocellular carcinoma: where are we?Effective inhibition of xenografts of hepatocellular carcinoma (HepG2) by rapamycin and bevacizumab in an intrahepatic model.

P2860

Q24654739-DFBA1FC5-294E-4896-85B9-F1149A853C20 Q26772329-200E64AC-D600-4EC8-9D4A-9FD6580442CC Q26772334-6D71A3A1-9E0C-490A-9D59-9EAB17C329C9 Q26773119-246A5C5E-6C9F-49CE-A09E-A47B52D216A0 Q26784218-53677E72-8EE8-4DC0-8C32-6C8457247CA7 Q26866367-6F2E5675-AB68-4D9C-AD46-D09FBB4ED5DD Q26997064-D8ACB218-B585-4D6C-941E-2652EC1AA975 Q26998606-0D808303-D5FE-4151-90E6-A581E33800F4 Q27691331-9751C56F-200A-4B5B-8C76-98CFB9EC0530 Q30479629-0C09E8F8-2889-4A2A-9D55-0B6BFD62065C Q33704297-5BB6C1F5-97B0-413D-B6CE-E359D3919D46 Q33704392-2811B746-4B8C-476F-AD8B-02538B41E415 Q33840534-0F6D9A9F-C72D-4E08-9A8E-C530B0FD1155 Q34104182-0CF6D6CD-F537-45F5-84AB-2C687B961A4F Q34784909-8576280D-EA0D-414E-9379-935F3DF12B74 Q34950780-072C3F9E-E454-40BF-8E65-2FBE559E817C Q35127213-F8BEF957-F759-41FF-9E8B-5F4647792768 Q35154056-29CD6F2D-CD13-4403-9F72-6E4A931DB0D4 Q35187951-4600E272-ECF6-4E75-B537-69108391DAA9 Q35568722-10DE0BC1-3EEE-4CAF-A7E2-323E0C7EA700 Q35626234-40FC3F96-9758-4BF7-9C58-21EDA0C42585 Q35675742-3CA6723C-A7A5-4403-8170-E0A2695E1415 Q35747156-3C909E0C-F6D6-4ACC-86EA-1EC37AE82C70 Q35806757-6172805A-2871-4F17-8141-4E2A32981445 Q35925442-74473C6F-1123-45A8-B817-3967603CE171 Q36049920-5A2B7919-8CDE-40FF-8E7C-86B0AA75BD39 Q36066047-655993D6-CA95-4861-A301-3C76B3954522 Q36166863-F8EC9762-9963-4102-AEC0-2A2A817A77DC Q36171275-9FF457DF-BBB9-40B7-BC92-91FFC7FB4D22 Q36448703-154E30AD-6B2C-4BD0-9D78-FB81AD681C6E Q36568339-2CE2D0AB-3162-45A2-9D85-6F4FC51A574A Q36570279-B02572E0-2F68-405F-9CBD-6705765EAC3F Q36687495-B185C843-D716-4819-863C-F505D93AF480 Q36845960-D99B1167-842B-4367-9045-417F7EB0D1BC Q36901233-21D893EC-A64E-4D01-A548-48488D974094 Q36910493-9E5C1FBC-0319-4383-86BE-401EE6F359C1 Q37034083-D917AB95-1E3C-4239-908B-CA24291B71CD Q37037547-B2C55B2C-7E02-4946-ADC2-545AEAF376CC Q37088265-BAF7C0E0-316D-40A2-911C-BBC10DA19D4D Q37286152-EF6E4213-228F-47BE-90DF-AE4C7727D62A

P2860

Positron emission tomography scanning in the evaluation of hepatocellular carcinoma.

http://www.wikidata.org/entity/Q33939061

description

2000 nî lūn-bûn

@nan

2000 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2000 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2000年の論文

@ja

2000年論文

@yue

2000年論文

@zh-hant

2000年論文

@zh-hk

2000年論文

@zh-mo

2000年論文

@zh-tw

2000年论文

@wuu

name

Positron emission tomography scanning in the evaluation of hepatocellular carcinoma.

@ast

Positron emission tomography scanning in the evaluation of hepatocellular carcinoma.

@en

type

label

Positron emission tomography scanning in the evaluation of hepatocellular carcinoma.

@ast

Positron emission tomography scanning in the evaluation of hepatocellular carcinoma.

@en

prefLabel

Positron emission tomography scanning in the evaluation of hepatocellular carcinoma.

@ast

Positron emission tomography scanning in the evaluation of hepatocellular carcinoma.

@en

P1433

Q33939061-E23773C7-CB65-4060-941A-711287A9F86B

P1476

Q33939061-4C0E7AC6-F851-4156-9955-20C6FC19E3E7

P2093

Q33939061-4108527B-323F-40B9-99B3-E5A6125F4280

Q33939061-497EBC42-AA34-42D9-8D44-15072361254F

Q33939061-75281A35-E3C1-4827-BB06-A931088BF225

Q33939061-9203295A-3956-4669-AB19-DC0A1A868A08

Q33939061-CCB2AE25-39B0-4DBA-8D97-66C74E9E8E0B

Q33939061-E70B9CB4-124C-403F-A8CA-056274B8BEBE

Q33939061-E7E573A5-B553-48DA-8CF1-0A24D8195CBD

Q33939061-FE337D8A-F830-4CB3-91D3-54E5C6C3B223

P304

Q33939061-CEA58888-DD14-42EB-8C82-28C476E6D543

P31

Q33939061-C8F79F64-1E09-4E4B-9FEE-4CB83C689B70

P356

Q33939061-86F0A0F9-79D9-4CAF-BACC-735F1F988AC2

P433

Q33939061-1403C408-8303-4C40-89C5-76F801D0E466

P478

Q33939061-0CE90DAE-7344-4FBB-AA03-536C9EC2522A

P577

Q33939061-29EBEA01-3C16-4951-8C07-D5C27236AA80

P698

Q33939061-9F249D90-6C88-45BB-A090-9EB334084BD7

P356

S0168-8278(00)80248-2

P1433

Journal of Hepatology

P1476

Positron emission tomography scanning in the evaluation of hepatocellular carcinoma.

@en

P2093

Brunt EM

http://www.w3.org/2001/XMLSchema#string

Collins BT

http://www.w3.org/2001/XMLSchema#string

Combs CS

http://www.w3.org/2001/XMLSchema#string

Di Bisceglie AM

http://www.w3.org/2001/XMLSchema#string

Khan MA

http://www.w3.org/2001/XMLSchema#string

Lowe VJ

http://www.w3.org/2001/XMLSchema#string

Solomon H

http://www.w3.org/2001/XMLSchema#string

Wolverson MK

http://www.w3.org/2001/XMLSchema#string

P304

792-797

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/S0168-8278(00)80248-2

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

32

http://www.w3.org/2001/XMLSchema#string

P577

2000-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

10845666

http://www.w3.org/2001/XMLSchema#string